1. Home
  2. XBIO vs VRME Comparison

XBIO vs VRME Comparison

Compare XBIO & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$2.75

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.63

Market Cap

8.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
VRME
Founded
N/A
1999
Country
United States
United States
Employees
2
30
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
8.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XBIO
VRME
Price
$2.75
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$1.50
AVG Volume (30 Days)
13.9K
51.5K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.81
$36.85
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.59
52 Week High
$13.93
$1.51

Technical Indicators

Market Signals
Indicator
XBIO
VRME
Relative Strength Index (RSI) 53.16 47.99
Support Level $2.89 $0.64
Resistance Level $3.25 $0.93
Average True Range (ATR) 0.17 0.04
MACD 0.01 0.01
Stochastic Oscillator 73.80 55.48

Price Performance

Historical Comparison
XBIO
VRME

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

Share on Social Networks: